0,847  0,005  Caspase 9 stimulant
0,713  0,013  Antineoplastic (colorectal cancer)
0,710  0,013  Antineoplastic (colon cancer)
0,681  0,020  Antineoplastic (lung cancer)
0,648  0,008  Antineoplastic (non-small cell lung cancer)
0,634  0,007  DNA damaging
0,605  0,013  Antineoplastic (melanoma)
0,574  0,012  Caspase 3 stimulant
0,585  0,025  Antineoplastic (solid tumors)
0,565  0,008  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,570  0,021  Prostate cancer treatment
0,546  0,009  Antineoplastic (glioblastoma multiforme)
0,545  0,010  Dyrk kinase inhibitor
0,543  0,008  Antineoplastic (lymphoma)
0,538  0,005  Topoisomerase II inhibitor
0,543  0,013  Antineoplastic (glioma)
0,544  0,017  Histamine release inhibitor
0,562  0,041  Antineoplastic (breast cancer)
0,572  0,055  Apoptosis agonist
0,508  0,004  Neurotrophic factor enhancer
0,508  0,007  Antineoplastic (small cell lung cancer)
0,512  0,018  Antineoplastic (brain cancer)
0,490  0,004  Topoisomerase I inhibitor
0,493  0,008  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,504  0,023  CYP1A2 substrate
0,488  0,010  Antineoplastic (renal cancer)
0,501  0,027  Antineoplastic (ovarian cancer)
0,495  0,040  Antileukemic
0,455  0,009  Tubulin antagonist
0,475  0,031  CYP2C19 inhibitor
0,439  0,006  DNA intercalator
0,438  0,016  Antineoplastic enhancer
0,419  0,016  Clk dual-specificity kinase inhibitor
0,416  0,021  Antimitotic
0,405  0,011  Antineoplastic (squamous cell carcinoma)
0,422  0,028  Antineoplastic (multiple myeloma)
0,401  0,019  Antineoplastic (lymphocytic leukemia)
0,398  0,022  Sigma receptor agonist
0,410  0,034  Antineoplastic (cervical cancer)
0,440  0,068  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,380  0,012  Male reproductive disfunction treatment
0,425  0,058  Transcription factor NF kappa B inhibitor
0,398  0,032  CYP1A2 inhibitor
0,379  0,014  Antineoplastic (carcinoma)
0,427  0,063  15-Lipoxygenase inhibitor
0,398  0,038  Aryl hydrocarbon receptor agonist
0,362  0,005  CDC-like kinase 1 inhibitor
0,374  0,019  Antineoplastic (bladder cancer)
0,375  0,020  Cyclic AMP phosphodiesterase inhibitor
0,357  0,010  Erectile dysfunction treatment
0,371  0,027  Pyruvate kinase inhibitor
0,338  0,014  Genotoxic
0,346  0,024  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,341  0,023  CDC-like kinase 4 inhibitor
0,343  0,025  Antiparkinsonian, rigidity relieving
0,368  0,052  5 Hydroxytryptamine release stimulant
0,320  0,006  Topoisomerase II alpha inhibitor
0,372  0,073  CYP2C9 substrate
0,327  0,030  Antineoplastic (sarcoma)
0,354  0,058  Hepatic disorders treatment
0,334  0,045  Antiprotozoal (Leishmania)
0,328  0,044  Tumour necrosis factor alpha release inhibitor
0,324  0,041  Vasodilator
0,304  0,024  Protein kinase C nu inhibitor
0,306  0,027  MAP-kinase-activated kinase 5 inhibitor
0,292  0,018  Liver fibrosis treatment
0,327  0,054  Hypoxia-inducible factor 1 alpha inhibitor
0,277  0,005  Phosphodiesterase V inhibitor
0,289  0,018  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,298  0,030  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,287  0,019  Glycogen synthase kinase-3 alpha inhibitor
0,300  0,034  Ca2+/calmodulin-dependent kinase II gamma inhibitor
0,313  0,049  Cytostatic
0,360  0,107  5 Hydroxytryptamine release inhibitor
0,303  0,050  Antineoplastic (liver cancer)
0,252  0,005  MAP3K9 inhibitor
0,251  0,005  Antineoplastic alkaloid
0,331  0,086  CYP3A4 substrate
0,245  0,005  Phosphodiesterase 5A inhibitor
0,242  0,004  CDC-like kinase 3 inhibitor
0,250  0,016  5 Hydroxytryptamine 3E antagonist
0,306  0,073  Respiratory analeptic
0,299  0,071  Antineoplastic (osteosarcoma)
0,268  0,041  RNA-directed DNA polymerase inhibitor
0,275  0,049  5 Hydroxytryptamine 1E antagonist
0,309  0,088  Angiogenesis inhibitor
0,278  0,057  Acute neurologic disorders treatment
0,231  0,011  Breast cancer-resistant protein inhibitor
0,315  0,095  Prostaglandin dehydrogenase inhibitor
0,236  0,016  5 Hydroxytryptamine 2A antagonist
0,223  0,005  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,245  0,029  Melanin inhibitor
0,235  0,019  Cyclin-dependent kinase 3 inhibitor
0,237  0,023  5 Hydroxytryptamine 2 antagonist
0,232  0,019  ATPase inhibitor
0,227  0,018  Alpha 2b adrenoreceptor antagonist
0,231  0,026  Heat shock protein 90 antagonist
0,228  0,025  Antineoplastic (bone cancer)
0,250  0,047  VCAM1 expression inhibitor
0,226  0,024  MAO A inhibitor
0,222  0,023  Antiviral (Hepatitis B)
0,301  0,105  Stroke treatment
0,220  0,024  Alpha adrenoreceptor antagonist
0,242  0,048  CDC-like kinase 2 inhibitor
0,208  0,016  5 Hydroxytryptamine 1 antagonist
0,196  0,005  Phosphodiesterase 11A inhibitor
0,196  0,005  Phosphodiesterase XI inhibitor
0,204  0,014  5 Hydroxytryptamine 1A antagonist
0,201  0,012  Protein kinase C mu inhibitor
0,269  0,082  Antineoplastic (pancreatic cancer)
0,232  0,049  Hepatoprotectant
0,276  0,102  Antihypertensive
0,180  0,007  Alpha tubulin antagonist
0,204  0,033  Phobic disorders treatment
0,189  0,018  Polo-like kinase-4 inhibitor
0,183  0,013  DNA repair enzyme inhibitor
0,201  0,034  Carcinogenic, group 1
0,220  0,055  Focal adhesion kinase 2 inhibitor
0,199  0,035  Death-associated protein kinase 2 inhibitor
0,246  0,085  Antiprotozoal (Trypanosoma)
0,211  0,051  Muscle relaxant
0,316  0,157  DNA polymerase beta inhibitor
0,218  0,060  Abortion inducer
0,271  0,113  Vasodilator, peripheral
0,214  0,056  P-glycoprotein inhibitor
0,178  0,021  Alpha 2 adrenoreceptor antagonist
0,192  0,035  Acetylcholinesterase inhibitor
0,193  0,037  Phosphodiesterase inhibitor
0,232  0,076  Cardiodepressant
0,161  0,005  Phosphodiesterase VI inhibitor
0,190  0,036  5 Hydroxytryptamine antagonist
0,194  0,042  MAO inhibitor
0,191  0,041  Activin receptor-like kinase 2 inhibitor
0,167  0,017  Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor
0,173  0,027  Interleukin 1b antagonist
0,175  0,028  MAP kinase kinase 4 inhibitor
0,229  0,083  NOS2 expression inhibitor
0,178  0,034  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,195  0,052  Heat shock protein 90 alpha antagonist
0,155  0,014  Check point kinase 1 inhibitor
0,252  0,114  CYP3A4 inhibitor
0,203  0,064  Chemopreventive
0,176  0,039  Psychosexual dysfunction treatment
0,147  0,010  Phosphodiesterase 6D inhibitor
0,163  0,027  Alpha 2c adrenoreceptor antagonist
0,280  0,144  TNF expression inhibitor
0,170  0,037  Alkylator
0,158  0,025  Antiviral (Papilloma)
0,221  0,093  DNA synthesis inhibitor
0,133  0,007  AMPA receptor antagonist
0,197  0,074  I kappa B kinase epsilon inhibitor
0,132  0,010  Protein kinase C eta inhibitor
0,128  0,005  Heat shock protein 90 beta antagonist
0,173  0,051  Skeletal muscle relaxant
0,198  0,076  Ca2+/calmodulin-dependent protein kinase inhibitor
0,264  0,148  CYP2C9 inhibitor
0,250  0,134  Vasodilator, coronary
0,131  0,015  Beta tubulin antagonist
0,173  0,059  Uterine stimulant
0,219  0,106  Spasmolytic
0,282  0,169  Alpha-glucosidase inhibitor
0,181  0,069  Antineoplastic (gastric cancer)
0,138  0,026  Carcinogenic, group 2A
0,264  0,154  Antineoplastic (myeloid leukemia)
0,222  0,112  Ca2+/calmodulin-dependent kinase IV inhibitor
0,144  0,035  Protein kinase C gamma inhibitor
0,121  0,019  ATPase (Vacuolar H+) inhibitor
0,124  0,024  MAP-kinase-activated kinase inhibitor
0,124  0,025  Telomerase inhibitor
0,168  0,070  Catenin beta inhibitor
0,165  0,067  Antiviral (Herpes)
0,220  0,123  Analeptic
0,108  0,012  5 Hydroxytryptamine 2A agonist
0,181  0,087  Cytotoxic
0,115  0,022  MAP-kinase-activated kinase 2 inhibitor
0,124  0,031  Phosphodiesterase IV inhibitor
0,102  0,010  Glutamate (mGluR7) antagonist
0,123  0,031  Dopamine antagonist
0,218  0,127  CYP2D6 substrate
0,095  0,005  Endothelin receptor antagonist
0,270  0,179  DNA directed DNA polymerase inhibitor
0,131  0,041  Activin receptor-like kinase 4 inhibitor
0,162  0,072  Cystic fibrosis treatment
0,098  0,008  Poly(ADP-ribose) polymerase inhibitor
0,117  0,027  Restless leg syndrome treatment
0,206  0,118  Proliferative diseases treatment
0,115  0,028  Dopamine D2 antagonist
0,172  0,086  Antiviral (Hepatitis)
0,155  0,070  Aldose reductase substrate
0,188  0,103  ErbB-1 antagonist
0,127  0,043  Butyrylcholinesterase inhibitor
0,131  0,048  Carcinogenic, group 2B
0,178  0,096  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,144  0,062  Heat shock protein 70 antagonist
0,159  0,077  Src kinase inhibitor
0,107  0,025  Antiviral (Hepatitis A)
0,152  0,071  Antiischemic, cerebral
0,160  0,081  Mutagenic
0,117  0,038  Alpha 1 adrenoreceptor antagonist
0,157  0,079  Interleukin 6 antagonist
0,110  0,032  Alpha 2a adrenoreceptor antagonist
0,092  0,015  Protein kinase C epsilon inhibitor
0,140  0,062  NADPH oxidase inhibitor
0,213  0,136  CYP2D6 inhibitor
0,213  0,137  12-Lipoxygenase inhibitor
0,118  0,046  Antiadrenergic
0,090  0,019  Protein kinase C beta inhibitor
0,116  0,045  Adrenaline antagonist
0,120  0,050  MAO B inhibitor
0,137  0,068  Interleukin 1 antagonist
0,095  0,027  Dopamine D1 antagonist
0,082  0,014  5 Hydroxytryptamine 2 agonist
0,154  0,086  Mcl-1 antagonist
0,085  0,021  5 Hydroxytryptamine 5A antagonist
0,069  0,005  Endothelin B receptor antagonist
0,157  0,092  Tumour necrosis factor antagonist
0,098  0,034  5 Hydroxytryptamine agonist
0,075  0,013  Ryanodine receptor antagonist
0,121  0,059  5 Hydroxytryptamine 2B antagonist
0,097  0,036  mTOR complex 2 inhibitor
0,092  0,032  Cyclin B3 inhibitor
0,257  0,197  Calcium channel L-type activator
0,088  0,029  Dopamine D3 antagonist
0,217  0,158  GST M1-1 substrate
0,186  0,126  Antioxidant
0,163  0,104  Death-associated protein kinase 3 inhibitor
0,087  0,029  Protein kinase C alpha inhibitor
0,133  0,074  Antifungal enhancer
0,074  0,016  5 Hydroxytryptamine 7 agonist
0,270  0,212  MAP kinase 1 inhibitor
0,094  0,038  Alpha 1a adrenoreceptor antagonist
0,102  0,046  Calcium antagonist
0,086  0,031  Phosphodiesterase III inhibitor
0,108  0,053  Antifungal (Aspergillus)
0,164  0,109  MAP kinase kinase 2 inhibitor
0,076  0,022  5 Hydroxytryptamine 5 antagonist
0,198  0,144  Antiischemic
0,107  0,053  Insulin receptor antagonist
0,196  0,144  Radiosensitizer
0,138  0,087  Cholinergic
0,090  0,039  Alpha 1b adrenoreceptor antagonist
0,097  0,047  Protein kinase A inhibitor
0,054  0,005  Endothelin A receptor antagonist
0,067  0,020  5 Hydroxytryptamine 1B agonist
0,137  0,093  GABA C receptor rho-2 antagonist
0,056  0,012  Phosphodiesterase 6C inhibitor
0,095  0,051  Phosphodiesterase I inhibitor
0,243  0,199  MAP kinase kinase 6 inhibitor
0,151  0,107  Amyloid beta aggregation inhibitor
0,144  0,100  Nitric oxide antagonist
0,058  0,014  Poly(ADP-ribose) polymerase 1 inhibitor
0,109  0,068  Cyclin-dependent kinase 5 inhibitor
0,048  0,008  Phosphodiesterase 6B inhibitor
0,118  0,080  Cyclooxygenase 3 inhibitor
0,080  0,042  GABA B receptor agonist
0,045  0,008  Protein kinase C beta II inhibitor
0,120  0,085  Antineoplastic (uterine cancer)
0,088  0,053  Myeloperoxidase inhibitor
0,102  0,067  Cyclin-dependent kinase 2 inhibitor
0,164  0,130  Free radical scavenger
0,162  0,128  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,107  0,073  Glycogen synthase kinase-3 inhibitor
0,063  0,030  Bromodomain-containing protein 4 inhibitor
0,143  0,111  Sedative
0,149  0,117  Psychostimulant
0,169  0,137  Antipyretic
0,143  0,113  3C-like protease (Human coronavirus) inhibitor
0,147  0,116  LDLR expression enhancer
0,092  0,062  Protein kinase C zeta inhibitor
0,117  0,089  Papain-like protease (SARS coronavirus) inhibitor
0,083  0,055  Caspase 7 inhibitor
0,088  0,064  Protein kinase C delta inhibitor
0,067  0,044  5 Hydroxytryptamine 1B antagonist
0,050  0,027  Dopamine D2 agonist
0,068  0,046  Dopamine agonist
0,068  0,046  Female sexual dysfunction treatment
0,112  0,091  Ca2+/calmodulin-dependent kinase II delta inhibitor
0,033  0,012  Dopamine autoreceptor agonist
0,028  0,009  Phosphodiesterase 6H inhibitor
0,028  0,009  Phosphodiesterase 6G inhibitor
0,105  0,087  Antiseptic
0,074  0,057  Antitreponemal
0,050  0,034  Factor III inhibitor
0,179  0,164  Lipoxygenase inhibitor
0,168  0,153  Cardiotonic
0,122  0,107  Death-associated protein kinase 1 inhibitor
0,118  0,103  Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor
0,169  0,155  Radioprotector
0,050  0,036  CD45 antagonist
0,062  0,048  CDC25B inhibitor
0,037  0,024  5 Hydroxytryptamine 3B antagonist
0,096  0,083  Glycogen synthase kinase-3 beta inhibitor
0,059  0,046  5 Hydroxytryptamine 7 antagonist
0,213  0,200  Antineoplastic (endocrine cancer)
0,050  0,038  5 Hydroxytryptamine 1 agonist
0,024  0,014  Phosphodiesterase 6A inhibitor
0,203  0,192  Antiprotozoal (Plasmodium)
0,055  0,045  Protein kinase C iota inhibitor
0,032  0,024  Melatonin 1 agonist
0,067  0,061  Acetylcholine M4 receptor antagonist
0,060  0,053  Prolactin release inhibitor
0,094  0,088  DOPA decarboxylase inhibitor
0,032  0,026  Protein kinase C beta I inhibitor
0,027  0,021  Poly(ADP-ribose) polymerase 2 inhibitor
0,097  0,092  c-Src kinase inhibitor
0,059  0,053  Cyclin-dependent kinase 4 inhibitor
0,102  0,097  Cyclooxygenase 1 inhibitor
0,038  0,033  Acid-sensing ion channel blocker
0,067  0,063  CDC25A inhibitor
0,041  0,037  5 Hydroxytryptamine 1A agonist
0,147  0,143  CYP2B6 inhibitor
0,123  0,120  Pregnane X receptor agonist
0,076  0,073  Thioredoxin reductase inhibitor
0,210  0,209  Antiprotozoal
0,096  0,095  Cyclin-dependent kinase inhibitor

